Lauren M. Green

Screening for distress, which effects 60% of patients with cancer, improve confidence in nurses and other clinicians about their ability to deliver personalized cancer care.

Neoadjuvant chemotherapy (NACT) in treating advanced ovarian cancer has brought improvement s to quality of life and morbidity, but there are still issues within its use, such as choosing the best candidates.

A number of risk factors can play a role in nonadherence, including older age, memory issues, and depression.

For survivors suffering from chemotherapy-induced cognitive symptoms, known as "chemobrain," new web-based memory and mental exercises could offer relief.

When Breast Cancer Awareness Month arrives each October, for many women there is a lot to be thankful for. Research advances have led to less aggressive treatment options and a good prognosis for women with early-stage disease, but for women with metastatic breast cancer (MBC), it is a different story.

In 2014, Novartis Oncology commissioned the Harris Poll to conduct the Make Your Dialogue Count survey to identify the emotional needs of patients newly diagnosed with metastatic breast cancer as well as during treatment change.

Immunotherapy is changing the cancer treatment game as therapies continue to be approved for more and more tumor types. This creates more responsibilities for oncology nurses.

Oncology nurses invited to 2016 Chemotherapy Foundation Symposium with a special CE-accredited learning track.

Studies find the addition of rolapitant to the CINV regimen gave a clinically meaningful benefit with no added toxicity.

Patients undergoing chemotherapy prescribed a formal exercise program experienced less chemotherapy-induced peripheral neuropathy (CIPN), and the finding held true across all chemotherapy regimens tested.

Although paradigms for treating older patients with head and neck cancer are not well defined, advancements in targeted and immunotherapies and less toxic radiation regimens suggest that physicians can aim for a more individualized approach to treating this patient population.

A study of women treated with the mTOR inhibitor everolimus plus exemestane for their advanced breast cancer found that daily use of an alcohol-free, steroid-based mouthwash markedly decreased the incidence and severity of stomatitis, and the researchers recommend that this preventive regimen become standard of care in this setting.

Healthcare practitioners know all too well how technology has transformed their workplace. These changes can be a bane or a blessing—sometimes both—as many nurses and other clinicians will attest.

Researchers at the Dana-Farber Cancer Institute are testing a psychoeducational intervention that they hope will offer relief for sexual problems after treatment.

As the number of older cancer survivors continues to grow, health researchers are looking for ways to combine healthy aging with healthy survivorship. It turns out that a relatively simple solution may be found in a survivor’s own backyard.

Patients who are anxious and fearful as they embark on a course of radiotherapy to treat their cancer may find relief from those symptoms through relaxation techniques.

For uninsured patients who are at a high risk for colorectal cancer (CRC), performing free screening colonoscopies can identify cancer at an earlier stage and appears to be cost neutral from a hospital system perspective.

Young black women with breast cancer are much less likely to have BRCA testing or, if they carry a BRCA mutation, to undergo risk-reducing prophylactic mastectomy or salpingo-oophorectomy.

Women who extended their adjuvant therapy with an aromatase inhibitor (AI) to 10 years after treatment for their early-stage HR-positive breast cancer reduced their risk of recurrence by more than a third and experienced no new toxicities or worsening of quality of life.

Researchers are hoping that a new nationwide effort aimed at helping patients to share their tumor samples and clinical information will lead to new discoveries and better treatments for metastatic breast cancer.

Results of a new study show that women who typically slept less than the recommended 7 hours per night and were frequent snorers in the years before their cancer diagnosis experienced a poorer prognosis.

A retrospective analysis conducted by researchers at Kaiser Permanente and UCLA has concluded that patients with breast cancer treated with aromatase inhibitors (AIs) as adjuvant endocrine therapy were at equal risk of serious cardiovascular disease (CVD) events as those treated with tamoxifen.

With genetic profiles and genomic targeting increasingly impacting treatment decisions, patients and families would welcome a one-stop place where they can find resources to help unravel all this complex information.

Although androgen deprivation therapy (ADT) has a survival benefit for patients with high-risk and locally advanced prostate cancer, it is associated with substantial safety concerns, and mixed data exist regarding whether ADT causes clinically significant depression.

A study of more than 2400 women with early-stage breast cancer has found that those who fasted 13 hours or more at night reduced their risk of breast cancer recurrence, findings that suggest prolonging the nightly fasting interval may offer a relatively safe nonpharmacologic way for women with early breast cancer to lower their risk of disease recurrence.

Developing a skin rash as a result of EGFR-inhibitor targeted therapy often signals that the drug is working, but for patients who experience these serious dermatologic adverse events, it may become so intolerable that they will scale back or even discontinue anticancer medications that could prolong their survival.

West Cancer Center researchers developed a best nursing practice protocol for titration of fentanyl sublingual spray, which is the most recently approved transmucosal immediate-release fentanyl formulation.

When oncology nurses move proactively to learn more about and use proven effective “green-lighted” interventions like exercise and muscle relaxation in their daily practice, it can go a long way in helping patients and their caregivers manage symptoms associated with a cancer diagnosis like fatigue and anxiety.

An intervention specifically aimed at reducing the trauma and anxiety that often comes with parenting a child undergoing hematopoietic stem cell transplant proved especially helpful for parents during the time of the actual transplant and subsequent hospitalization.